Literature DB >> 16945668

Renal scarring in familial vesicoureteral reflux: is prevention possible?

Martina E Pirker1, Eric Colhoun, Prem Puri.   

Abstract

PURPOSE: Detailed knowledge about risk factors for renal scarring in familial reflux is necessary to decide whether these factors could be influenced by early screening and treatment of siblings. We evaluated the prevalence of and risk factors influencing renal scarring in familial vesicoureteral reflux.
MATERIALS AND METHODS: We reviewed the medical records and dimercapto-succinic acid scans of 306 children with familial vesicoureteral reflux. Scarring was classified as mild, moderate and severe. The impact of urinary tract infections, patient sex, reflux grade and age at diagnosis on renal scarring was evaluated.
RESULTS: The prevalence of renal scarring was identical at 36% in 142 index patients and 74 siblings presenting with urinary tract infection but it was only 10% in 87 asymptomatic siblings (p <0.001) The difference between siblings with and without urinary tract infection was only statistically significant for mild scarring (23% vs 4.6%, p <0.001). It did not attain significance in those with moderate to severe scarring (13.5% vs 5.7%). Moderate to severe scarring was significantly more common in grade V than in grade IV refluxing units (43% vs 10%, p <0.0001) and in male than in female siblings (15.8% vs 3.4%, p = 0.012). Mild scarring was not significantly associated with reflux grade or patient sex. Children diagnosed before age 3 years showed significantly less scarring than patients diagnosed later (23% vs 41%, p <0.002).
CONCLUSIONS: The development of mild renal scarring seems to mainly depend on urinary tract infections, while moderate and severe scarring are also associated with high grade reflux and male sex. Early detection and treatment may prevent further urinary tract infections as well as reflux related kidney damage.

Entities:  

Mesh:

Year:  2006        PMID: 16945668     DOI: 10.1016/j.juro.2006.04.089

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  A genome-wide scan for genes involved in primary vesicoureteric reflux.

Authors:  H Kelly; C M Molony; J M Darlow; M E Pirker; A Yoneda; A J Green; P Puri; D E Barton
Journal:  J Med Genet       Date:  2007-07-27       Impact factor: 6.318

Review 2.  Genetics of vesicoureteral reflux.

Authors:  Prem Puri; Jan-Hendrik Gosemann; John Darlow; David E Barton
Journal:  Nat Rev Urol       Date:  2011-08-23       Impact factor: 14.432

Review 3.  Diagnosis and management of vesicoureteral reflux in children.

Authors:  Christopher S Cooper
Journal:  Nat Rev Urol       Date:  2009-08-11       Impact factor: 14.432

4.  Association of Genetic Polymorphisms in GSTP1, GSTM1, and GSTT1 Genes with Vesicoureteral Reflux Susceptibility in the Children of Southeast Iran.

Authors:  Sima Shahrokhzadeh; Azam Soleimani; Dor-Mohammad Kordi-Tamandani; Mohammad Hossein Sangtarash; Omid Nejati; Mohsen Taheri
Journal:  Iran J Public Health       Date:  2020-07       Impact factor: 1.429

5.  The predictive factors of hydronephrosis in patients with spina bifida: reports from China.

Authors:  Yan Ma; Bing Li; Longwang Wang; Xiaomin Han
Journal:  Int Urol Nephrol       Date:  2013-03-13       Impact factor: 2.370

6.  Vesicoureteral reflux, a benign condition.

Authors:  Mika Venhola; Matti Uhari
Journal:  Pediatr Nephrol       Date:  2008-07-05       Impact factor: 3.714

7.  Primary Vesico-Ureteral Reflux: Comparison of Factors between Infants and Children.

Authors:  Hyeon Chan Jang; Kyung Hun Lee; Jae Shin Park
Journal:  Korean J Urol       Date:  2011-03-18

8.  Color-Doppler sonographic tissue perfusion measurements reveal significantly diminished renal cortical perfusion in kidneys with vesicoureteral reflux.

Authors:  T M Scholbach; C Sachse
Journal:  Indian J Nephrol       Date:  2016 Mar-Apr

9.  Genetics of Vesicoureteral Reflux.

Authors:  F Nino; M Ilari; C Noviello; L Santoro; I M Rätsch; A Martino; G Cobellis
Journal:  Curr Genomics       Date:  2016-02       Impact factor: 2.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.